For over 25 years, Lonza has been helping emerging biotech and pharmaceutical companies improve and advance their products. Whether you are in the early stages of clinical development or providing commercial product to patients around the globe, Lonza supplies complete development services, industry-leading manufacturing, and broad technology platforms that enable products to reach their full potential… Read More
McSAF is a start-up developing new chemical tools for bioconjugation, with core capabilities that span across the modification of payloads and proteins, and the development of next-generation ADCs. Our current R&D focus is the design and optimisation of rebridging heads; these versatile structures are based on our patented bioconjugation technologies and allow the production of an enriched DAR4 population. [Read More]
Merck, a leading science and technology company in life science, helps customers advance production capabilities while increasing access to therapies for people worldwide. The development of an ADC requires expertise in small and large molecule handling, manufacturing, formulation and testing. Choosing an experienced partner, with these skills and the required containment facilities can help advance your ADC to market. Whether you are seeking to build your process based on our tailored technology platforms, a service provider – or a combination of both, we can collaborate with you. www.MerckMillipore.com/adcservices
NBE-Therapeutics is a Swiss Biotechnology company developing antibody-based therapeutics. It is the main focus of NBE-Therapeutics to develop antibody drug conjugates (ADCs) for targeted cancer therapy. For this NBE-Therapeutics has developed proprietary therapeutic antibody discovery and antibody-drug conjugation technologies allowing the development of superior, “next-generation” ADCs.
Novasep provides unique services for the development and cGMP manufacture of antibody-drug conjugates including the payload, the linker and the monoclonal antibody. With a recent €10M investment in a fully integrated ADC facility, Novasep has reinforced its current ADC offering with full bio-conjugation services to meet increasing market demand.
PROVEO IS YOUR ADC ALLIANCE
Formed in 2016, PROVEO™ is a four-company CMO alliance providing seamless, end-to-end solutions for the process development and cGMP manufacture of ADCs. Combining integrated project management, logistics, supply chain, and production— Read More
European leader in analytical sciences – Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products. The company holds a unique position on the market thanks to having all its laboratories on one site, 170 highly qualified professionals and more than 35 years’ expertise at the forefront of analytical sciences.
Sartorius-Stedim Biotech is a key supplier of Bioprocessing technologies and Biomanufacturing related services.
Benefit from the most comprehensive bioprocess and single-use technology portfolio coupled with our process engineering expertise, ensuring a robust process development and manufacturing approach… Read more
SCIEX enables drug discovery and development for biologics and small molecule drugs. From identification through peptide mapping and sequence variance analysis ― our advanced LC/MS, LC/MS/MS and CE solutions reduce complexity across the entire process. SCIEX strives to exceed expectations and empower customers to find accurate answers.